EUVIMEDEUVIMED entdecken
Crossref

Amniotic Membrane‐Derived Extracellular Matrix for Developing a Cost‐Effective Xenofree Hepatocellular Carcinoma Organoid Model

Dina Atta, Ahmed M Abou-Shanab, Samaa Samir Kamar, Mariam Waleed Soliman, Shireen Magdy, Nagwa El-Badri iD

Journal of Biomedical Materials Research Part A · 2025

DOI: 10.1002/jbm.a.37882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biomedical Materials Research Part A, 2025. Verfasst von Dina Atta und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center of Excellence for Stem Cells and Regenerative Medicine, Zewail City of Science and Technology, Giza, Egypt. Hauptthemen laut MEDLINE: Organoids, Carcinoma, Hepatocellular, Extracellular Matrix, Amnion. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 97 Literaturangaben. Gefördert von: Egyptian Academy of Scientific Research and Technology (ASRT): JESOR grant (Grant # 5275), Science and Technology Development Fund (STDF): FLUG grant (Grant # 46721), Science and Technology Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Current limitations in the treatment of hepatocellular carcinoma (HCC) include tumor recurrence, chemoresistance, and severe side effects, all of which call for novel cancer models that better represent the tumor microenvironment (TME). 3D organoids hold promise due to their increased relevance to the TME hallmarks. Herein, we aim to establish an HCC organoid model that mimics the HCC microenvironment and its metabolic interactome. The organoid comprises a decellularized human amniotic membrane (dAM) as a biomimetic matrix, Huh‐7 cell line, bone marrow mesenchymal stromal cells (BM‐MSC), and human umbilical vein endothelial cell‐conditioned medium (HUVEC‐CM). The structure integrity of the HCC organoid was monitored using H&E staining at 7, 14, and 21 days and transmission electron microscopy (TEM) and scanning electron microscopy (SEM) at 21 days. The established organoid model maintained its viability over 21 days as tested by propidium iodide (PI) fluorescence staining, MTT, upregulated expression of proliferating cell nuclear antigen (PCNA), and alpha‐fetoprotein (AFP). The expression of vascular endothelial growth factor (VEGF) in the HCC organoid induced a neo‐angiogenic response in ovo. Metabolic reprogramming in the HCC organoid showed a shift toward glycolysis as indicated by promoted glucose consumption, upregulated lactate production, and reduced cellular pyruvate concentration. Oxidative phosphorylation was suppressed as indicated by reduced reactive oxygen species (ROS), and hydrogen peroxide (H 2 O 2 ), and halted urea cycle progression. The dataset shows that the dAM may hold a promise for its use as extracellular matrix (ECM) source for HCC organoid models, by replicating the HCC microenvironment and metabolic signature, thus holding a promise for developing targeted therapeutic strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OrganoidsCarcinoma, HepatocellularExtracellular MatrixAmnionLiver NeoplasmsModels, BiologicalHumansCell Line, TumorMesenchymal Stem CellsTumor MicroenvironmentAnimalsHuman Umbilical Vein Endothelial Cells

Stichwörter der Autor:innen

amniotic membraneextracellular matrixhepatocellular carcinomaorganoid

Autor:innen und Institutionen

  • Center of Excellence for Stem Cells and Regenerative Medicine, Zewail City of Science and Technology, Giza, Egypt.
  • Biomedical Sciences Program, University of Science and Technology, Zewail City of Science and Technology, Giza, Egypt.
  • Histology Department, Kasr Al-Ainy Faculty of Medicine, Cairo University, Cairo, Egypt.

ORCID-Profile: Nagwa El-Badri

Förderung

  • Egyptian Academy of Scientific Research and Technology (ASRT): JESOR grant (Grant # 5275)
  • Science and Technology Development Fund (STDF): FLUG grant (Grant # 46721)
  • Science and Technology Development Fund

Zitieren

APA

Atta, D., Abou-Shanab, A. M., Kamar, S. S., Soliman, M. W., Magdy, S., & El-Badri, N. (2025). Amniotic Membrane‐Derived Extracellular Matrix for Developing a Cost‐Effective Xenofree Hepatocellular Carcinoma Organoid Model. Journal of Biomedical Materials Research Part A. https://doi.org/10.1002/jbm.a.37882

Vancouver

Atta D, Abou-Shanab AM, Kamar SS, Soliman MW, Magdy S, El-Badri N. Amniotic Membrane‐Derived Extracellular Matrix for Developing a Cost‐Effective Xenofree Hepatocellular Carcinoma Organoid Model. Journal of Biomedical Materials Research Part A. 2025. doi:10.1002/jbm.a.37882

BibTeX
@article{Atta2025,
  author = {Atta, Dina and Abou-Shanab, Ahmed M and Kamar, Samaa Samir and Soliman, Mariam Waleed and Magdy, Shireen and El-Badri, Nagwa},
  title = {Amniotic Membrane‐Derived Extracellular Matrix for Developing a Cost‐Effective Xenofree Hepatocellular Carcinoma Organoid Model},
  journal = {Journal of Biomedical Materials Research Part A},
  year = {2025},
  doi = {10.1002/jbm.a.37882}
}
Kostenlos starten →